Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study

Addeo, A; Rothschild, SI; Holer, L; Schneider, M; Waibel, C; Haefliger, S; Mark, M; Fernandez, E; Mach, N; Mauti, L; Jermann, PM; Alborelli, I; Calgua, B; Savic-Prince, S; Joerger, M; Fruh, M

Joerger, M (通讯作者)，Kantonsspital, Dept Oncol & Hematol, CH-9007 St Gallen, Switzerland.

LUNG CANCER, 2022; 172 (): 154

Abstract

Background: Patients with advanced squamous-cell lung cancer (SQCLC) frequently (46%) exhibit tumor overexpression of fibroblast growth factor recepto......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索